clpC1 Family assigned · medium auto-curated

H37Rv Rv3596c · MTBC0 - · 848 aa · 4038158–4040704 H37Rv (-) · RefSeq YP_177995.1

Genomic neighbourhood (genome browser)

Open in full genome browser →

This gene (outlined) in its genomic context; arrows are neighbouring genes coloured by verdict. Click any gene to navigate. Pan and zoom in the full browser.

Annotation: from legacy to revised

Legacy (H37Rv / Mycobrowser)ATP-dependent protease ATP-binding subunit ClpC
MTBC0 PGAP re-annotation—
Revised (this work)ATP-dependent protease ATP-binding subunit ClpC. Pfam: Clp_N (PF02861.26), NBD_SMAX1 (PF23569.2), TniB (PF05621.18), AAA (PF00004.36), AAA_lid_9 (PF17871.8), UVR (PF02151.26), Sigma54_activat (PF00158.33), AAA_2 (PF07724.21), AAA_5 (PF07728.21), ClpB_D2-small (PF10431.16).
Functional category (TubercuList)intermediary metabolism and respiration

Auto-curated: this verdict and function were generated by rules from PGAP + Pfam + Foldseek and have not been hand-reviewed.

Annotated on the H37Rv protein: this gene has no 1:1 ancestral MTBC0 anchor (PE/PPE, paralogue, IS element, or otherwise unanchored CDS).

In the literature (TB corpus sweep) 82 publications

82 TB publications mention this gene. 82 publications discuss this gene. Queried separately, 76 records carry a M. tuberculosis context and 10 a non-TB mycobacterial context (species named in the 10-record verified sample: M. smegmatis (5), M. abscessus (4), M. leprae (1)). The three counts come from three distinct PubMed queries (each with its own context filter), so they neither partition the total nor need to add up to it.

5 of 82: the most recently indexed records of the curated sweep at its date, not necessarily the most recent papers on this gene — the exhaustive list below is later and broader and may hold newer ones.
PublicationDate
Phosphoarginine modulates oligomerization and repressor activity of mycobacterial ClpC2. doi:10.64898/2026.06.30.735635 2026
ClpC1-dependent iron homeostasis underlies mycobacterial defense against oxygen-driven Fenton reaction during reactivation. doi:10.1128/spectrum.00496-26 2026
Activation mechanism and structural assembly of the Mycobacterium tuberculosis ClpP1P2 protease and its associated ATPases. doi:10.1016/j.celrep.2026.117400 2026
Effects of mutations conferring pyrazinamide resistance among multidrug-resistant tuberculosis isolates from China. doi:10.1128/spectrum.00641-26 2026
ClpC1-targeting peptide natural products differentially dysregulate the proteome of Mycobacterium tuberculosis. doi:10.1038/s41467-026-68423-2 2026
84 records returned by the alias sweep (a separate sweep from the 82 above; both are shown, neither is exhaustive)

Searched as: Rv3596c, clpC1, Mb3627c, ML0235, MMAR_5100, MSMEG_6091, MAB_0546 — each in conjunction with a mycobacterial context term. Swept 2026-09-07.

PublicationJournalYear
Phosphoarginine modulates oligomerization and repressor activity of mycobacterial ClpC2. doi:10.64898/2026.06.30.735635 bioRxiv 2026
ClpC1-dependent iron homeostasis underlies mycobacterial defense against oxygen-driven Fenton reaction during reactivation. doi:10.1128/spectrum.00496-26 names it Microbiol Spectr 2026
Activation mechanism and structural assembly of the Mycobacterium tuberculosis ClpP1P2 protease and its associated ATPases. doi:10.1016/j.celrep.2026.117400 Cell Rep 2026
Effects of mutations conferring pyrazinamide resistance among multidrug-resistant tuberculosis isolates from China. doi:10.1128/spectrum.00641-26 Microbiol Spectr 2026
ClpC1-targeting peptide natural products differentially dysregulate the proteome of Mycobacterium tuberculosis. doi:10.1038/s41467-026-68423-2 names it Nat Commun 2026
Unique Interactions of Novel Rufomycin "Click Chemistry" Analogs with Mtb ClpC1 and Implications. doi:10.1021/acs.jmedchem.5c02416 names it J Med Chem 2025
ClpC1 Modulating Ohmyungsamycin A and Ecumicin Natural Product Analogues are Potent Antimycobacterials. doi:10.1021/acsinfecdis.5c00689 names it ACS Infect Dis 2025
Natural Products with Potent Antimycobacterial Activity (2000-2024): A Review. doi:10.3390/molecules30183708 Molecules 2025
Synthesis of a Conformationally Fixed Bicyclomarin Derivative. doi:10.1002/cmdc.202500493 ChemMedChem 2025
Mutations in ClpC1 or ClpX subunit of caseinolytic protease confer resistance to ilamycins in mycobacteria. doi:10.1038/s42003-025-08646-z names it Commun Biol 2025
Harnessing caseinolytic proteases ClpP1P2 for next-generation antimycobacterial agents: Mechanisms, challenges and opportunities. doi:10.1016/j.ejmech.2025.117858 Eur J Med Chem 2025
The Identification of Novel Mutations in ATP-Dependent Protease ClpC1 Assists in the Molecular Diagnosis of Obscured Pyrazinamide-Resistant Tuberculosis Clinical Isolates. doi:10.3390/microorganisms13061401 names it Microorganisms 2025
Structure-Based Analysis of Semisynthetic Anti-TB Rufomycin Analogues. doi:10.1021/acs.jnatprod.4c01266 J Nat Prod 2025
MdfA is a novel ClpC adaptor protein that functions in the developing Bacillus subtilis spore. doi:10.1101/gad.352498.124 Genes Dev 2025
Author Correction: Identification of new ClpC1-NTD binders for Mycobacterium tuberculosis drug development. doi:10.1038/s41598-025-92778-z names it Sci Rep 2025
Identification of new ClpC1-NTD binders for Mycobacterium tuberculosis drug development. doi:10.1038/s41598-025-87535-1 names it Sci Rep 2025
Engineered Mycobacterium tuberculosis triple-kill-switch strain provides controlled tuberculosis infection in animal models. doi:10.1038/s41564-024-01913-5 Nat Microbiol 2025
ClpS Directs Degradation of N-Degron Substrates With Primary Destabilizing Residues in Mycolicibacterium smegmatis. doi:10.1111/mmi.15334 Mol Microbiol 2025
Phenotypic and genotypic characterization of Mycobacterium tuberculosis pyrazinamide resistance-India, 2018-2020. doi:10.3389/fmicb.2024.1515627 Front Microbiol 2024
Discovery of anti-Mycobacterium tuberculosis desertomycins from Streptomyces flavofungini TRM90047 based on genome mining and HSQC-TOCSY. doi:10.1038/s41598-024-65702-0 Sci Rep 2024
Homo-BacPROTAC-induced degradation of ClpC1 as a strategy against drug-resistant mycobacteria. doi:10.1038/s41467-024-46218-7 names it Nat Commun 2024
Metabolites from Streptomyces aureus (VTCC43181) and Their Inhibition of Mycobacterium tuberculosis ClpC1 Protein. doi:10.3390/molecules29030720 names it Molecules 2024
Crystal structure of the N-terminal domain of MtClpC1 in complex with the anti-mycobacterial natural peptide Lassomycin. doi:10.1016/j.ijbiomac.2023.126771 Int J Biol Macromol 2023
Interactome Analysis Identifies MSMEI_3879 as a Substrate of Mycolicibacterium smegmatis ClpC1. doi:10.1128/spectrum.04548-22 names it Microbiol Spectr 2023
Clp-targeting BacPROTACs impair mycobacterial proteostasis and survival. doi:10.1016/j.cell.2023.04.009 Cell 2023
HtpG Is a Metal-Dependent Chaperone Which Assists the DnaK/DnaJ/GrpE Chaperone System of Mycobacterium tuberculosis via Direct Association with DnaJ2. doi:10.1128/spectrum.00312-23 Microbiol Spectr 2023
ClpC2 protects mycobacteria against a natural antibiotic targeting ClpC1-dependent protein degradation. doi:10.1038/s42003-023-04658-9 names it Commun Biol 2023
Identification of the inhibitory mechanism of ecumicin and rufomycin 4-7 on the proteolytic activity of Mycobacterium tuberculosis ClpC1/ClpP1/ClpP2 complex. doi:10.1016/j.tube.2022.102298 names it Tuberculosis (Edinb) 2023
Acyldepsipeptide Antibiotics and a Bioactive Fragment Thereof Differentially Perturb Mycobacterium tuberculosis ClpXP1P2 Activity in Vitro. doi:10.1021/acschembio.9b00454 ACS Chem Biol 2023
Total Synthesis and Biological Evaluation of Modified Ilamycin Derivatives. doi:10.3390/md20100632 Mar Drugs 2022
Structure of the drug target ClpC1 unfoldase in action provides insights on antibiotic mechanism of action. doi:10.1016/j.jbc.2022.102553 names it J Biol Chem 2022
Antibacterial peptide CyclomarinA creates toxicity by deregulating the Mycobacterium tuberculosis ClpC1-ClpP1P2 protease. doi:10.1016/j.jbc.2022.102202 names it J Biol Chem 2022
Potential therapeutic targets from Mycobacterium abscessus (Mab): recently reported efforts towards the discovery of novel antibacterial agents to treat Mab infections. doi:10.1039/d1md00359c RSC Med Chem 2022
The essential M. tuberculosis Clp protease is functionally asymmetric in vivo. doi:10.1126/sciadv.abn7943 Sci Adv 2022
Potent Bactericidal Antimycobacterials Targeting the Chaperone ClpC1 Based on the Depsipeptide Natural Products Ecumicin and Ohmyungsamycin A. doi:10.1021/acs.jmedchem.1c02122 names it J Med Chem 2022
Role of HrcA in stress management in Mycobacterium tuberculosis. doi:10.1111/jam.15428 J Appl Microbiol 2022
Rufomycin Exhibits Dual Effects Against Mycobacterium abscessus Infection by Inducing Host Defense and Antimicrobial Activities. doi:10.3389/fmicb.2021.695024 Front Microbiol 2021
Recent Developments on the Synthesis and Bioactivity of Ilamycins/Rufomycins and Cyclomarins, Marine Cyclopeptides That Demonstrate Anti-Malaria and Anti-Tuberculosis Activity. doi:10.3390/md19080446 Mar Drugs 2021
In Vitro Profiling of Antitubercular Compounds by Rapid, Efficient, and Nondestructive Assays Using Autoluminescent Mycobacterium tuberculosis. doi:10.1128/AAC.00282-21 Antimicrob Agents Chemother 2021
Overcoming the Challenges of Pyrazinamide Susceptibility Testing in Clinical Mycobacterium tuberculosis Isolates. doi:10.1128/AAC.02617-20 Antimicrob Agents Chemother 2021
Atypical Genetic Basis of Pyrazinamide Resistance in Monoresistant Mycobacterium tuberculosis. doi:10.1128/AAC.01916-20 Antimicrob Agents Chemother 2021
Biosynthetic Interrogation of Soil Metagenomes Reveals Metamarin, an Uncommon Cyclomarin Congener with Activity against Mycobacterium tuberculosis. doi:10.1021/acs.jnatprod.0c01104 J Nat Prod 2021
ClpXP-mediated Degradation of the TAC Antitoxin is Neutralized by the SecB-like Chaperone in Mycobacterium tuberculosis. doi:10.1016/j.jmb.2021.166815 J Mol Biol 2021
ClpX Is Essential and Activated by Single-Strand DNA Binding Protein in Mycobacteria. doi:10.1128/JB.00608-20 J Bacteriol 2021
Exploring a potential Achilles heel of Mycobacterium tuberculosis: defining the ClpC1 interactome. doi:10.1111/febs.15430 names it FEBS J 2021
Genome-wide interaction screen for Mycobacterium tuberculosis ClpCP protease reveals toxin-antitoxin systems as a major substrate class. doi:10.1111/febs.15335 FEBS J 2021
The unfoldase ClpC1 of Mycobacterium tuberculosis regulates the expression of a distinct subset of proteins having intrinsically disordered termini. doi:10.1074/jbc.RA120.013456 names it J Biol Chem 2020
Structure of the N-terminal domain of ClpC1 in complex with the antituberculosis natural product ecumicin reveals unique binding interactions. doi:10.1107/S2059798320004027 names it Acta Crystallogr D Struct Biol 2020
Pyrazinamide triggers degradation of its target aspartate decarboxylase. doi:10.1038/s41467-020-15516-1 Nat Commun 2020
Detection of Novel Gene Mutations Associated with Pyrazinamide Resistance in Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates in Southern China. doi:10.2147/IDR.S230774 Infect Drug Resist 2020
An allosteric switch regulates Mycobacterium tuberculosis ClpP1P2 protease function as established by cryo-EM and methyl-TROSY NMR. doi:10.1073/pnas.1921630117 Proc Natl Acad Sci U S A 2020
Antimycobacterial Rufomycin Analogues from Streptomyces atratus Strain MJM3502. doi:10.1021/acs.jnatprod.9b01095 J Nat Prod 2020
High-Resolution Structure of ClpC1-Rufomycin and Ligand Binding Studies Provide a Framework to Design and Optimize Anti-Tuberculosis Leads. doi:10.1021/acsinfecdis.8b00276 names it ACS Infect Dis 2019
Rufomycin Targets ClpC1 Proteolysis in Mycobacterium tuberculosis and M. abscessus. doi:10.1128/AAC.02204-18 names it Antimicrob Agents Chemother 2019
Development of high throughput screening methods for inhibitors of ClpC1P1P2 from Mycobacteria tuberculosis. doi:10.1016/j.ab.2018.12.004 Anal Biochem 2019
Mycobacterium tuberculosis ClpC1 N-Terminal Domain Is Dispensable for Adaptor Protein-Dependent Allosteric Regulation. doi:10.3390/ijms19113651 names it Int J Mol Sci 2018
The Role of ClpP Protease in Bacterial Pathogenesis and Human Diseases. doi:10.1021/acschembio.8b00124 ACS Chem Biol 2018
Identification of Novel Mutations in LprG (rv1411c), rv0521, rv3630, rv0010c, ppsC, and cyp128 Associated with Pyrazinoic Acid/Pyrazinamide Resistance in Mycobacterium tuberculosis. doi:10.1128/AAC.00430-18 Antimicrob Agents Chemother 2018
The antibiotic cyclomarin blocks arginine-phosphate-induced millisecond dynamics in the N-terminal domain of ClpC1 from Mycobacterium tuberculosis. doi:10.1074/jbc.RA118.002251 names it J Biol Chem 2018
Identification of Novel Efflux Proteins Rv0191, Rv3756c, Rv3008, and Rv1667c Involved in Pyrazinamide Resistance in Mycobacterium tuberculosis. doi:10.1128/AAC.00940-17 Antimicrob Agents Chemother 2017
Mutation analysis of the interactions between Mycobacterium tuberculosis caseinolytic protease C1 (ClpC1) and ecumicin. doi:10.1016/j.ijbiomac.2017.03.126 names it Int J Biol Macromol 2017
Crystal structures reveal N-terminal Domain of Arabidopsis thaliana ClpD to be highly divergent from that of ClpC1. doi:10.1038/srep44366 names it Sci Rep 2017
In Vivo-Selected Pyrazinoic Acid-Resistant Mycobacterium tuberculosis Strains Harbor Missense Mutations in the Aspartate Decarboxylase PanD and the Unfoldase ClpC1. doi:10.1021/acsinfecdis.7b00017 names it ACS Infect Dis 2017
Mutation in clpC1 encoding an ATP-dependent ATPase involved in protein degradation is associated with pyrazinamide resistance in Mycobacterium tuberculosis. doi:10.1038/emi.2017.1 names it Emerg Microbes Infect 2017
Missense Mutations in the Unfoldase ClpC1 of the Caseinolytic Protease Complex Are Associated with Pyrazinamide Resistance in Mycobacterium tuberculosis. doi:10.1128/AAC.02342-16 names it Antimicrob Agents Chemother 2017
Acyldepsipeptide antibiotics kill mycobacteria by preventing the physiological functions of the ClpP1P2 protease. doi:10.1111/mmi.13362 Mol Microbiol 2016
Structure and Functional Properties of the Active Form of the Proteolytic Complex, ClpP1P2, from Mycobacterium tuberculosis. doi:10.1074/jbc.M115.700344 J Biol Chem 2016
Anti-tuberculosis lead molecules from natural products targeting Mycobacterium tuberculosis ClpC1. doi:10.1007/s10295-015-1709-3 names it J Ind Microbiol Biotechnol 2016
Gift from Nature: Cyclomarin A Kills Mycobacteria and Malaria Parasites by Distinct Modes of Action. doi:10.1002/cbic.201500472 Chembiochem 2015
RETRACTED: Targeting Mycobacterial Enzymes with Natural Products. doi:10.1016/j.chembiol.2015.08.012 Chem Biol 2015
Correction: The Mycobacterium tuberculosis ClpP1P2 Protease Interacts Asymmetrically with Its ATPase Partners ClpX and ClpC1. doi:10.1371/journal.pone.0131132 names it PLoS One 2015
The Mycobacterium tuberculosis ClpP1P2 Protease Interacts Asymmetrically with Its ATPase Partners ClpX and ClpC1. doi:10.1371/journal.pone.0125345 names it PLoS One 2015
The cyclic peptide ecumicin targeting ClpC1 is active against Mycobacterium tuberculosis in vivo. doi:10.1128/AAC.04054-14 names it Antimicrob Agents Chemother 2015
Substrate delivery by the AAA+ ClpX and ClpC1 unfoldases activates the mycobacterial ClpP1P2 peptidase. doi:10.1111/mmi.12694 names it Mol Microbiol 2014
Targeting mycobacterial proteolytic complexes with natural products. doi:10.1016/j.chembiol.2014.04.002 Chem Biol 2014
Lassomycin, a ribosomally synthesized cyclic peptide, kills mycobacterium tuberculosis by targeting the ATP-dependent protease ClpC1P1P2. doi:10.1016/j.chembiol.2014.01.014 Chem Biol 2014
Structural basis of mycobacterial inhibition by cyclomarin A. doi:10.1074/jbc.M113.493767 J Biol Chem 2013
The C-terminus of ClpC1 of Mycobacterium tuberculosis is crucial for its oligomerization and function. doi:10.1371/journal.pone.0051261 names it PLoS One 2012
The active ClpP protease from M. tuberculosis is a complex composed of a heptameric ClpP1 and a ClpP2 ring. doi:10.1038/emboj.2012.5 EMBO J 2012
The natural product cyclomarin kills Mycobacterium tuberculosis by targeting the ClpC1 subunit of the caseinolytic protease. doi:10.1002/anie.201101740 names it Angew Chem Int Ed Engl 2011
RseA, the SigE specific anti-sigma factor of Mycobacterium tuberculosis, is inactivated by phosphorylation-dependent ClpC1P2 proteolysis. doi:10.1111/j.1365-2958.2009.07008.x Mol Microbiol 2010
Mycobacterium tuberculosis ClpC1: characterization and role of the N-terminal domain in its function. doi:10.1111/j.1742-4658.2008.06738.x names it FEBS J 2008
Expression analysis of proteases of Mycobacterium leprae in human skin lesions. doi:10.1016/j.micpath.2007.05.011 Microb Pathog 2007
Dissecting virulence pathways of Mycobacterium tuberculosis through protein-protein association. doi:10.1073/pnas.0602817103 Proc Natl Acad Sci U S A 2006

Title+abstract index only: a paper that names this gene solely in its body text, a figure legend or a supplement is invisible here. That is why this list sits beside the curated layer rather than replacing it - Rv0007's characterisation, found by a full-text sweep, returns zero in this one. Absence from this list is not absence from the literature. Source: PubMed E-utilities sweep (esearch + esummary), every alias of the gene searched in conjunction with a mycobacterial context term; ambiguous common-word aliases excluded. phase198, 2026-09-06.

This layer CITES the literature and adds context; it does not change the verdict or the function stated elsewhere in this fiche. This distinguishes a gene that is dark because nobody has looked from one that is dark despite having been studied. Source: PubMed (whole): H37Rv locus tag + GENE NAME + ortholog identifiers (Mb…, MMAR_…, MSMEG_…, ML…, MAB_…), under a mycobacterial context filter; hits verified against the abstract text. Species-context counts distinguish M. tuberculosis literature from literature on other mycobacteria. phase76/phase77, 2026-07-13.

CRISPRi vulnerability

Vulnerability index -10.57 (95% CI -11.32 to -9.78). A more negative index = more vulnerable to knockdown (better drug-target quality); indicative threshold VI ≤ -6 = highly vulnerable.

Quantitative CRISPRi knockdown, graded (finer than binary Tn-seq essentiality). Source: CRISPRi vulnerability index (Bosch 2021, supplementary Table S2 'mmc3.xlsx', bulk import via Europe PMC -- supersedes the per-gene pebble.rockefeller.edu scrape of phase46_crispri_vulnerability.py).

Legacy record & comparison (Mycobrowser)

Mycobrowser functionHydrolyses proteins in presence of ATP. May interact with a CLPP-like protease involved in degradation of denatured proteins.

The legacy Mycobrowser record is shown for verification. Mycobrowser is no longer maintained; its EC numbers predate recent nomenclature revisions, so a class change usually reflects re-numbering, not a conflict.

Orthologues (reciprocal best hits across mycobacteria)

M. bovis Mb3627c · 100.0% identity
M. leprae ML0235 · 97.2% identity
M. marinum MMAR_5100 · 98.1% identity
M. smegmatis MSMEG_6091 · 94.4% identity
M. orygis RJtmp_003704 · 100.0% identity
M. abscessus MAB_0546 · 94.2% identity

Reciprocal-best-hit orthologues (DIAMOND) against the Mycobrowser reference proteomes. A missing species is informative: e.g. a gene absent from M. leprae was likely lost in its reductive genome evolution. Locus tags link to Mycobrowser.

Curated reference (UniProt)

UniProt P9WPC9 SwissProt · reviewed · Evidence at protein level
UniProt nameATP-dependent Clp protease ATP-binding subunit ClpC1
Curated functionATP-dependent specificity component of the Clp protease. It directs the protease to specific substrates. Can perform chaperone functions in the absence of ClpP (By similarity). Degrades anti-sigma-E factor RseA in the presence of ClpP2.

Functional vocabulary (eggNOG-mapper, orthology transfer)

COG category O Post-translational modification, protein turnover, chaperones
Preferred nameclpC
eggNOG descriptionwith chaperone activity, ATP-binding subunit
Orthologous groupCOG0542
KEGG orthology K03696
KEGG pathways map01100
Gene Ontology (31) GO:0003674, GO:0003824, GO:0005488, GO:0005515, GO:0005575, GO:0005618, GO:0005622, GO:0005623, GO:0005737, GO:0005829, GO:0005886, GO:0006457 +19 more

Orthology-based transfer (eggNOG 5.0.2, diamond). EC/KO/GO/CAZy are computed annotations, not manual curation; cross-check against the primary literature before treating a specific reaction as established.

Conservation & selection (intra-MTBC, 142 601 strains, snapshot of 2026-09-29)

pN/pS 0.165 · strong purifying
Polymorphic sites (≥ 0.1% of strains) 6 synonymous, 3 missense, 0 nonsense, 0 frameshift

pN/pS from segregating SNPs (singletons removed) normalised by possible sites. Low pN/pS = purifying selection (a strong signal that a "hypothetical" is a real, constrained gene). A high pN/pS is ambiguous: relaxed constraint or positive selection (drug resistance, antigenic variation) inflate it; e.g. rpoB/katG/pncA score high here for resistance, not loss of function. A clonal disruption (one allele over a clade) suggests lineage pseudogenisation; a convergent one (many independent alleles) is typical of resistance loss-of-function.

Outgroup conservation (beyond the MTBC) Bacteria

M. canettii dN/dS (deep-divergence selection) 0.0 · 49 consensus substitution(s)
under purifying selection vs M. canettii (deep divergence; dN/dS=0.0) — a real, constrained gene predating the MTBC clonal expansion
Limitation: dN/dS mixes fixed canettii-H37Rv divergence with intra-canettii polymorphism, and is not polarised (the per-gene repolarisation is not viable: 79 % of the consensus SPDI lie outside the polarised table).
Genus-wide presence (~53 non-MTBC Mycobacterium) present in 53/53 (100%) · mean identity 97.4% · 4/4 closest MTBAP relatives
conserved across the genus (present in 53/53 non-MTBC Mycobacterium genomes, incl. distant relatives) — an ancient core gene predating the genus radiation
Phylostratum (deepest detected homolog) MTBC-specific → Mycobacterium → Mycobacteriaceae → Corynebacteriales → Actinomycetia → Bacteria
detected in 13/13 non-Mycobacterium reference genomes (down to Bacteria) · mean identity 78.0%
detected down to outside the phylum (Proteobacteria/Firmicutes controls) — a universally conserved, ancient bacterial gene

Two orthogonal outgroup signals. M. canettii (the immediate outgroup) gives a deep-divergence dN/dS (a low value confirms a constrained, real gene; shown as confident only at ≥8 substitutions, else flagged low-power). Genus-wide presence/absence (tblastn vs assembled non-MTBC genomes) places the gene on the ancient-core ↔ MTBC-specific axis: a gene absent even from the closest MTBAP relatives is a candidate MTBC-specific innovation (possible host-adaptation factor, to confirm by synteny). The phylostratum extends that axis outside the genus (tblastn vs 13 reference genomes spanning Mycobacteriaceae → Corynebacteriales → Actinomycetia → outside the phylum): it is the deepest clade in which a homolog is still detected, i.e. a proxy for gene age. Read it with the null model in mind: a shallow (young) stratum can also reflect homology-detection failure for short or fast-evolving ORFs, so it is a descriptive axis, not a proof of novelty.

Essentiality (transposon mutagenesis) essential

DeJesus 2017 callES · essential
What the call meansessential: insertions absent across the whole ORF
TA sites (Himar1) 30 in the ORF — 29 in the essential state, 0 growth-defect, 1 non-essential, 0 growth-advantage. Saturation 0.033, mean read count 1. A region of the protein devoid of TA sites is invisible to this assay: nothing can be inferred about it, in either direction.
All 30 sites lie in this ORF alone (no overlapping CDS shares any), so the call is attributable to this gene.

Genome-wide Himar1 transposon essentiality in H37Rv (DeJesus 2017). An essential call (ES/ESD/GD) is strong, independent evidence that a "hypothetical" locus encodes a functional, selectively required gene — orthogonal to intra-species conservation.

Proteomics (mass spectrometry) detected

MS detectiondetected in 15 of 16 independent MS datasets
Integrated abundance958.0 ppm · rank 237/3519 (93.3th percentile)

Detection by mass spectrometry is direct, experimental evidence that the protein product exists — orthogonal to sequence conservation and to Tn-seq essentiality, and especially decisive for a "hypothetical" locus. Read the dataset count as abundance, not as replication. Measured across this atlas (3,491 detected proteins), the number of datasets a protein appears in tracks its abundance almost monotonically: median 1.2 ppm at 1 dataset of 16, 27 ppm at 10, 392 ppm at 15, 1,325 ppm at 16 — three orders of magnitude. A high count therefore says the protein is abundant more than it says several independent experiments confirmed it. What the count does establish, at any value, is that the product exists.

Predicted localisation (DeepTMHMM + lipobox) no export signal, no TM helix

Predictionno signal peptide, no TM helix (DeepTMHMM class GLOB)
DeepTMHMM classGLOB

A verified absence of signals, which is not a compartment. No Sec/Tat signal peptide, no transmembrane helix and no lipobox were found on this sequence. The predictor reports topology and export signals; it does not measure where the protein ends up, so this page draws no cytoplasmic conclusion from it. In M. tuberculosis that reservation is not theoretical: the 12 Esx paralogues of this atlas — EsxA/ESAT-6 and EsxB/CFP-10 among them, the best-established secreted proteins of the species — carry this very call, because substrates of the type VII (ESX) secretion system leave no recognisable signal. « Secreted » and « no signal peptide » are true together here.

Transmembrane topology and signal peptide from DeepTMHMM (deep-learning reference predictor); lipoproteins from a (myco)bacterial lipobox motif. A sequence-based prediction of subcellular context.

Physico-chemical properties (computed, ProtParam)

Length848 aa
Molecular weight93.6 kDa
Theoretical pI5.64
GRAVY-0.362 (hydrophilic)
Aliphatic index93.4
Aromaticity0.054
Instability index33.8 (stable)

Computed from the ancestral MTBC0 sequence with the ExPASy ProtParam method (Biopython). Descriptive biophysical context: a positive GRAVY flags a hydrophobic (often membrane) protein, a high instability index (>40) predicts a short in-vitro half-life, an extreme pI hints at compartment or binding partner.

Domains (Pfam, hmmscan --cut_ga)

PfamAccessioni-EvalueResiduesDescription
Clp_NPF02861.26 1.1e-374–126 Clp repeat (R) N-terminal domain
NBD_SMAX1PF23569.2 1.7e-07195–293 SMAX1 nucleotide binding domain
TniBPF05621.18 6.2e-05196–347 Bacterial TniB protein
AAAPF00004.36 1.1e-11213–325 ATPase family associated with various cellular activities (AAA)
AAA_lid_9PF17871.8 6.9e-34352–452 AAA lid domain
UVRPF02151.26 4.3e-07425–457 UvrB/uvrC motif
Sigma54_activatPF00158.33 3.4e-07531–649 Sigma-54 interaction domain
AAA_2PF07724.21 2.2e-64544–716 AAA domain (Cdc48 subfamily)
AAA_5PF07728.21 2.2e-10549–669 AAA domain (dynein-related subfamily)
ClpB_D2-smallPF10431.16 1.2e-25722–802 C-terminal, D2-small domain, of ClpB protein

3D structure (interactive — Mol*/pdbe-molstar)

Experimental structure 8a8v (PDBe), the strongest available structural evidence for this gene. Drag to rotate, scroll to zoom; hetero-groups (ligands, ions, waters hidden by default) shown as sticks.

Experimental structures (Protein Data Bank) 22 solved

PDBMethodResolutionCoverage
8a8v Electron Microscopy 3.34 Å 100%
8a8u Electron Microscopy 3.62 Å 100%
8a8w Electron Microscopy 4.29 Å 100%
9jvp Electron Microscopy 2.15 Å 78%
8ycx Electron Microscopy 2.2 Å 78%
8yd1 Electron Microscopy 2.81 Å 78%
9if4 Electron Microscopy 3.09 Å 78%
3wdc X-ray diffraction 1.18 Å 17%

Experimentally solved structures mapped from the UniProt accession via PDBe/SIFTS (22 total; up to 8 shown, ranked by sequence coverage then resolution). An experimental structure is direct proof of the folded product and the strongest structural evidence — superseding the predicted ESMFold/AlphaFold models below for any covered region.

Structural search (AlphaFold DB model, Foldseek vs PDB — genome-wide) pLDDT 82.8

PDB hitprobTM (aln)TM (query)TM (target)Seq. id.Cov. q / tE-valueDescription
8a8v-assembly1_E 1.00 0.91 0.62 0.91 87% 77% / 100% 8.6e-82 sig 8a8v-assembly1_E Mycobacterium tuberculosis ClpC1 hexamer structure bound to the natural product antibiotic Cyclomarin
8a8u-assembly1_D 1.00 0.90 0.63 0.90 88% 77% / 100% 1.2e-80 sig 8a8u-assembly1_D Mycobacterium tuberculosis ClpC1 hexamer structure
8a8w-assembly1_D 1.00 0.90 0.63 0.90 88% 77% / 100% 1.0e-79 sig 8a8w-assembly1_D Mycobacterium tuberculosis ClpC1 hexamer structure bound to the natural product antibiotic Ecumycin (class 1)
8a8w-assembly1_C 1.00 0.90 0.62 0.90 88% 77% / 100% 1.1e-78 sig 8a8w-assembly1_C Mycobacterium tuberculosis ClpC1 hexamer structure bound to the natural product antibiotic Ecumycin (class 1)
8xon-assembly1_R 1.00 0.88 0.63 0.88 72% 78% / 100% 5.8e-74 sig 8xon-assembly1_R Cryo-EM structure of the ClpC1:ClpP1P2 degradation complex in Streptomyces hawaiiensis

Foldseek search of the AlphaFold DB model (mean pLDDT 82.8, gated at 70) against the PDB — a genome-wide extension of the ESMFold dark-gene search that also covers proteins beyond the single-sequence length limit. Confident structural neighbours (E < 0.01) shown.

Genomic context (neighbours & predicted operon)

Upstream (5' on genome)PE_PGRS59 (- strand, 107 bp gap)
Downstream (3' on genome)lsr2 (- strand, 276 bp gap)

Neighbours from the H37Rv annotation (- strand). The operon is predicted by co-directional intergenic distance (same strand, gaps ≤50 bp) — a transcription-unit hypothesis, not a mapped TSS. For a "hypothetical", co-transcription with a characterised operon is a concrete functional lead (complements the STRING neighborhood channel below).

Published operon evidence (two independent sources)

Roback 2007 (logistic regression: distance + expression correlation, 474 microarrays) no multi-gene operon predicted (singleton)
REMap 2016 (RNA-seq coverage continuity, CDC1551, tag MT3703) exponential phase: operon of 3, Rv3595c · Rv3596c · Rv3597c (coverage 184.44)
expressed, no multi-gene operon (stationary phase, coverage 179.12) — agrees with the distance heuristic above

Two independent published operon maps, cited alongside the distance heuristic above: an association corroborating or contradicting the heuristic, never proof of shared function. REMap's RNA-seq coverage continuity is the most direct of the three signals; Roback's logistic regression and the intergenic-distance heuristic are statistical proxies.

Functional interaction network (STRING v12, guilt-by-association)

Explore full network →

Node colour = verdict, dashed = still uncharacterised; edge colour = evidence (green experimental, orange genomic-context, grey co-expression), width ∝ score. Click a partner to open its page; "Explore full network" to walk the graph.

Closest characterised functional partner: lsr2 (iron-regulated H-NS-like protein), high confidence (score 724, all STRING channels except text-mining; the partner is chosen on its genomic-context evidence).

Showing the 15 strongest of this gene's 71 partners at medium confidence (22 at high confidence). The table is an extract, not a neighbourhood: across the proteome the real median degree is 34 while the served median is 15, so no hub, degree distribution or centrality may be read on this table. Of the 71 partners, 3 rest on an interaction measured in M. tuberculosis itself.

PartnerProductScoreNo text-miningChannels (≥400)
Rv2460c clpP2 measured in Mtb ATP-dependent CLP protease proteolytic subunit 2 996 907 coexpression:478 experimental:754 textmining:963
Rv1331 clpS exp (transferred) ATP-dependent Clp protease adapter protein ClpS 955 851 experimental:773 textmining:712
Rv2461c clpP1 exp (transferred) ATP-dependent CLP protease proteolytic subunit 1 997 829 coexpression:487 experimental:529 textmining:984
Rv0350 dnaK exp (transferred) chaperone protein DnaK 906 814 coexpression:625 experimental:508 textmining:520
Rv0312 exp (transferred) hypothetical protein 832 808 coexpression:614 experimental:508
Rv3446c exp (transferred) hypothetical protein 832 808 coexpression:613 experimental:508
Rv2264c exp (transferred) hypothetical protein 832 808 coexpression:614 experimental:508
Rv0351 grpE stress response protein GrpE 908 768 coexpression:718 textmining:620
Rv3597c lsr2 iron-regulated H-NS-like protein 724 724 ctx neighborhood:721
Rv2373c dnaJ2 chaperone protein DnaJ 779 711 coexpression:539
Rv0352 dnaJ1 chaperone protein DnaJ 789 705 coexpression:530
Rv0251c hsp heat shock protein 771 705 coexpression:649
Rv2031c hspX alpha-crystallin 720 702 coexpression:646
Rv2299c htpG chaperone protein HtpG 767 700 coexpression:645
Rv3418c groES chaperonin GroES 721 581 coexpression:514

STRING combines evidence channels (neighborhood, fusion, cooccurrence, coexpression, experimental, database, text-mining) into a 0–1000 score. The ctx badge marks edges carried by the genomic-context channels (conserved neighborhood, fusion, phylogenetic co-occurrence), which are independent of orthology and structure and the strongest signal for an unknown gene. The no text-mining column recomputes the score from data alone, so a link that does not depend on the literature is visible. Association is a function hypothesis, not proof: corroborate with the operon context and the primary literature before assigning a function.

Where the experimental evidence comes from, and why it matters here. STRING's experimental channel fuses interactions measured in M. tuberculosis with interactions measured in another organism and transferred to this pair by orthology. The two are not equivalent for this atlas, whose standing rule is that better studied elsewhere is not a function established in M. tuberculosis. Measured on the served network: of the 38 229 partner pairs shown across the atlas, 13 483 partner rows carry a non-zero experimental channel, and only 106 pairs rest on an interaction measured in M. tuberculosis itself — 0.3 % of the network. Those 106 are long-established complexes (ESX-1/ESAT-6, RNA polymerase with CarD and RbpA, the Pup–Mpa proteasome, gyrase, Emb, GarA with PknB and PknG, the Rel modules); no still-uncharacterised gene is among them. The reason is not a gap in this atlas but in the literature: there is almost no experimental interactome of this bacterium, IntAct holding 134 curated protein pairs for a ~4 000-gene proteome. A exp (transferred) badge is therefore a lead, never a measurement, and an absence of badge is not evidence that the pair does not interact.

Evidence

  • Annotation from H37Rv (no MTBC0 1:1 anchor; H37Rv protein used): ATP-dependent protease ATP-binding subunit ClpC
  • Pfam (hmmscan --cut_ga): Clp_N PF02861.26 (E=1e-37), NBD_SMAX1 PF23569.2 (E=2e-07), TniB PF05621.18 (E=6e-05), AAA PF00004.36 (E=1e-11), AAA_lid_9 PF17871.8 (E=7e-34), UVR PF02151.26 (E=4e-07), Sigma54_activat PF00158.33 (E=3e-07), AAA_2 PF07724.21 (E=2e-64), AAA_5 PF07728.21 (E=2e-10), ClpB_D2-small PF10431.16 (E=1e-25)
  • (auto-curated by rules from PGAP + Pfam + Foldseek; not hand-reviewed)

Sources

  • Ancestral sequence & coordinates: Harrison LB et al. (2024), An imputed ancestral reference genome for the MTBC, doi:10.1101/2023.09.07.556366
  • Product annotation: NCBI PGAP on MTBC0; legacy from H37Rv NC_000962.3 (RefSeq YP_177995.1)
  • Domains: Pfam-A via hmmscan --cut_ga — Clp_N (PF02861.26), NBD_SMAX1 (PF23569.2), TniB (PF05621.18), AAA (PF00004.36), AAA_lid_9 (PF17871.8), UVR (PF02151.26), Sigma54_activat (PF00158.33), AAA_2 (PF07724.21), AAA_5 (PF07728.21), ClpB_D2-small (PF10431.16)
  • Sequence-level signal: ESM Atlas (EvolutionaryScale × BioHub) — exploratory
  • Controlled vocabulary: eggNOG-mapper 2.1.12 (Cantalapiedra et al. 2021, doi:10.1093/molbev/msab293), eggNOG 5.0 DB (Huerta-Cepas et al. 2019) — OG COG0542
  • Curated reference: UniProt P9WPC9 (SwissProt, reviewed; Evidence at protein level)
  • Intra-MTBC selection: pN/pS and disruption from SPDI variants of 142 601 MTBC strains (this work, local collection vs H37Rv NC_000962.3)
  • Genome-wide structure: AlphaFold DB model (Jumper et al. 2021, doi:10.1038/s41586-021-03819-2; Varadi et al. 2024, doi:10.1093/nar/gkad1011) searched vs PDB with Foldseek (mean pLDDT 82.8)
  • Interaction network: STRING v12.0 (Szklarczyk et al. 2023, doi:10.1093/nar/gkac1000), taxon 83332, CC-BY 4.0 — 71 functional partner(s); context anchor lsr2
  • Essentiality: genome-wide transposon mutagenesis in H37Rv — DeJesus et al. 2017 (mBio, doi:10.1128/mBio.02133-16, CC BY)
  • Proteomics: integrated mass-spectrometry abundance from PaxDb 5.0 (Huang et al. 2023, doi:10.1016/j.mcpro.2023.100640), taxon 83332 — weighted average of 16 datasets, incl. Schubert et al. 2013 (doi:10.1016/j.chom.2013.04.008) and Albrethsen et al. 2013 (doi:10.1074/mcp.M112.018846)
  • Functional category: TubercuList scheme (Cole et al. 1998, doi:10.1038/31159), via Mycobrowser (Kapopoulou et al. 2011, doi:10.1016/j.tube.2010.09.006)
  • Orthologues: reciprocal best hits (DIAMOND, Buchfink et al. 2021, doi:10.1038/s41592-021-01101-x) against Mycobrowser release 5 reference proteomes
  • Experimental structures: PDBe/SIFTS UniProt→PDB mapping (Dana et al. 2019, doi:10.1093/nar/gky1114)
  • Genomic context / operon: H37Rv annotation; operon predicted by co-directional intergenic distance (Salgado et al. 2000, doi:10.1073/pnas.030539397)
  • Physico-chemical properties: ExPASy ProtParam method via Biopython (Gasteiger et al. 2005), computed from the MTBC0 sequence
  • Predicted localisation: DeepTMHMM (Hallgren et al. 2022, doi:10.1101/2022.04.08.487609) for transmembrane topology and signal peptide
  • Primary literature: none located yet; annotation rests on the domain/homology sources above.

Ancestral MTBC0 protein sequence

>H37Rv|Rv3596c|clpC1
MFERFTDRARRVVVLAQEEARMLNHNYIGTEHILLGLIHEGEGVAAKSLESLGISLEGVRSQVEEIIGQGQQAPSGHIPFTPRAKKVLELSLREALQLGHNYIGTEHILLGLIREGEGVAAQVLVKLGAELTRVRQQVIQLLSGYQGKEAAEAGTGGRGGESGSPSTSLVLDQFGRNLTAAAMEGKLDPVIGREKEIERVMQVLSRRTKNNPVLIGEPGVGKTAVVEGLAQAIVHGEVPETLKDKQLYTLDLGSLVAGSRYRGDFEERLKKVLKEINTRGDIILFIDELHTLVGAGAAEGAIDAASILKPKLARGELQTIGATTLDEYRKYIEKDAALERRFQPVQVGEPTVEHTIEILKGLRDRYEAHHRVSITDAAMVAAATLADRYINDRFLPDKAIDLIDEAGARMRIRRMTAPPDLREFDEKIAEARREKESAIDAQDFEKAASLRDREKTLVAQRAEREKQWRSGDLDVVAEVDDEQIAEVLGNWTGIPVFKLTEAETTRLLRMEEELHKRIIGQEDAVKAVSKAIRRTRAGLKDPKRPSGSFIFAGPSGVGKTELSKALANFLFGDDDALIQIDMGEFHDRFTASRLFGAPPGYVGYEEGGQLTEKVRRKPFSVVLFDEIEKAHQEIYNSLLQVLEDGRLTDGQGRTVDFKNTVLIFTSNLGTSDISKPVGLGFSKGGGENDYERMKQKVNDELKKHFRPEFLNRIDDIIVFHQLTREEIIRMVDLMISRVAGQLKSKDMALVLTDAAKALLAKRGFDPVLGARPLRRTIQREIEDQLSEKILFEEVGPGQVVTVDVDNWDGEGPGEDAVFTFTGTRKPPAEPDLAKAGAHSAGGPEPAAR